Yin Li meets with the Executive Vice President and Global Chair of Medical Technology at Johnson & Johnson

Recently, Beijing Municipal Party Secretary Yin Li met with Dr. William (Bill) Anderson, Executive Vice President and Global Chair of Medical Technology at Johnson & Johnson. Yin Li stated that the pharmaceutical and health industry is one of the key industries for development in Beijing. The rich medical innovation resources, efficient and convenient approval services, and comprehensive industrial support policies provide a broad space for pharmaceutical companies to invest and develop in Beijing. The output value of Beijing's pharmaceutical industry has ranked first among Chinese cities for many years, and last year, the scale of the pharmaceutical and health industry broke through one trillion yuan for the first time. Currently, Beijing is striving to build a globally influential pharmaceutical and health industry cluster, and Johnson & Johnson is a leading comprehensive healthcare company worldwide. We are willing to further deepen cooperation with Johnson & Johnson, share greater development achievements, and work together to enhance the health and well-being of the people. We hope that Johnson & Johnson will expand its investment and business layout, actively engage in joint innovation with pharmaceutical companies, research institutions, clinical trial organizations, and artificial intelligence companies in Beijing, make good use of Beijing's advantages in customs clearance, approval, and other policies, introduce more innovative drugs, medical devices, and advanced therapies, strengthen the sharing of experiences in technological innovation and enterprise management, and promote exchanges in talent and information. Beijing will continue to optimize the business environment and fully serve enterprises' development in the city